Arthneeti

Borosil Scientific Q2 FY27 Share Price & Earnings Call Analysis

₹106.07+1.92% today
Market cap
₹944 Cr
P/E
20.41
ROE
10.52%
PEG
1.37
Price to sales
2.13
Debt to equity
0.00
52W high / low
₹174 / ₹101
EBITDA margin
16.06%
Net profit margin
10.94%
Promoter holding
68.27%
Sales (last year)
₹443 Cr

Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Industrial Products
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Borosil Scientific rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Industrial Products companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹448 Cr17.9
240%+Up 2%+₹413 Cr12.0
340%+Up 2%+₹324 Cr22.7
440%+Up 0–2%₹1,496 Cr32.8
540%+Up 0–2%₹1,079 Cr12.7
640%+Flat₹827 Cr21.4

Sign up free to see every company in the sector ranking and track Borosil Scientific.

Pro shows every company guiding 40%+ revenue growth →Full Industrial Products ranking

Financials of Borosil Scientific

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Borosil Scientific

Shareholding breakup across reporting periods.

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +67.92%67.86%67.84%67.81%67.80%67.80%67.80%68.08%68.27%68.27%
FIIs +0.38%0.37%0.27%0.24%0.20%0.07%0.07%0.09%0.23%0.14%
DIIs +0.15%0.01%0.02%0.02%0.05%0.10%0.19%0.26%0.26%0.27%
Public +31.54%31.74%31.88%31.91%31.93%32.03%31.93%31.57%31.22%31.30%
No. of Shareholders62,35461,20160,37358,89458,17857,58656,29755,31953,71253,066

Financials of Borosil Scientific

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +84.3588.42102.6693.4087.3893.65117.7089.0199.48107.12131.9299.90104.19
Expenses +71.8575.0183.7582.4473.7181.7496.3580.1587.2489.30100.8288.8492.99
Operating Profit12.5013.4118.9110.9613.6711.9121.358.8612.2417.8231.1011.0611.20
OPM %14.82%15.17%18.42%11.73%15.64%12.72%18.14%9.95%12.30%16.64%23.57%11.07%10.75%
Other Income +1.351.351.652.141.561.772.65-3.552.370.722.122.802.62
Interest0.270.340.510.240.180.180.180.180.090.090.060.100.08
Depreciation3.504.124.074.204.234.184.304.474.394.354.324.454.81
Profit before tax10.0810.3015.988.6610.829.3219.520.6610.1314.1028.849.318.93
Tax %23.12%27.67%24.47%25.29%28.93%28.33%27.41%30.30%25.77%27.59%25.35%26.42%30.01%
Net Profit +7.747.4512.076.477.696.6814.170.467.5210.2121.546.846.25
EPS in Rs0.841.360.730.870.751.590.050.851.152.420.770.70

Financials of Borosil Scientific

Profit & Loss

Annual income statement trend

Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +323353389424443
Expenses +272301330353372
Operating Profit5153587171
OPM %16%15%15%17%16%
Other Income +54818
Interest11100
Depreciation1215171818
Profit before tax4340485461
Tax %29%21%28%26%
Net Profit +3031354045
EPS in Rs3.543.944.475.04
Dividend Payout %0%0%0%0%

Financials of Borosil Scientific

Balance Sheet

Capital structure and asset base

Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital0.299999
Reserves352374411453467
Borrowings +1111611
Other Liabilities +6982748782
Total Liabilities432477499549558
Fixed Assets +150159155156168
CWIP81191
Investments3241146175175
Other Assets +241275197209214
Total Assets432477499549558

Financials of Borosil Scientific

Cash Flows

Operating, investing and financing cash movement

Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-573212750
Cash from Investing Activity +50-20-121-47
Cash from Financing Activity +7-1-5-4
Net Cash Flow0111-1
Free Cash Flow-852011425
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit-97%94%237%92%

Financials of Borosil Scientific

Ratios

Working capital efficiency and return ratios

Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days46546062
Inventory Days325256227232
Days Payable701027998
Cash Conversion Cycle301208207196
Working Capital Days1901819692
ROCE %11%12%14%
14out of 100

Momentum score · price trend

14 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−23.7%30%
Last 6 months−10.7%37%
Last 3 months−32.2%3%

The price is 51.4% below its all-time high of ₹213.95 (28 Jun 2024). Stocks more than 20% below their peak have their score halved, so 28 became 14.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Borosil Scientific: 0.4 × 30 + 0.4 × 37 + 0.2 × 3 = 28, halved to 14 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Borosil Scientific's management said in earlier quarters

Others in Industrial Products this season

  • Cosmo First (Q2 FY27)

    Q2 FY27 Net Revenue: ₹1,388 Cr, +51% YoY (vs ₹919 Cr in Q2 FY26) [Page 10, 3] . Key investor presentation takeaways from Cosmo First Ltd's Q2 FY27 investor pres

  • Inox India Ltd (Q2 FY27)

    Q2 FY27 revenue: ₹467 Cr, up 26.6% YoY from ₹369 Cr in Q2 FY26 (Page 20). Key investor presentation takeaways from Inox India Ltd's Q2 FY27 investor presentatio

  • Subros Ltd (Q2 FY27)

    1,198.90 Cr. Key investor presentation takeaways from Subros Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Graphite India (Q2 FY27)

    826 Crores, up 13.3% year-on-year (YoY) (Page 4, 9, 14) . Key investor presentation takeaways from Graphite India Ltd's Q2 FY27 investor presentation — and how

Compare:vs Cummins Indiavs Polycab Indiavs Welspun Corp Ltd